Related Experiment Videos
Clinical safety and efficacy of celiprolol
1Department of Clinical Research and Regulatory Affairs, Rhône-Poulenc Rorer Central Research, Horsham, PA 19002.
Insights
Celiprolol hydrochloride effectively manages essential hypertension by lowering diastolic blood pressure. This cardioselective beta-blocker offers a safe and favorable alternative with minimal impact on cardiovascular risk factors.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension management requires effective blood pressure reduction tailored to individual patient profiles.
- Therapeutic choices must consider patient demographics, comorbidities, and cardiovascular risk factors.
Purpose of the Study:
- To evaluate the efficacy and safety of celiprolol hydrochloride in treating essential hypertension.
- To assess celiprolol's impact on hemodynamic activity and cardiovascular risk factors.
Main Methods:
- Clinical evaluation of celiprolol hydrochloride in patients with essential hypertension.
- Comparative analysis of blood pressure control and safety profile against existing therapies.
Main Results:
- Celiprolol hydrochloride demonstrated effective blood pressure control, comparable to other antihypertensive therapies.
- The drug exhibited an excellent safety profile and favorable hemodynamic activity.
- Celiprolol showed minimal adverse effects on other cardiovascular risk factors.
Conclusions:
- Celiprolol hydrochloride is an effective and safe treatment option for essential hypertension.
- Its favorable safety and hemodynamic profile, with minimal impact on risk factors, makes it a unique therapeutic alternative.
Abstract:
The management of essential hypertension requires therapeutic selections that are not only effective in reducing diastolic blood pressure but are also tailored to the individual patient, with minimal effect on patient demographics, concurrent illnesses, and cardiovascular risk factors. Celiprolol hydrochloride is a new highly cardioselective vasodilating beta-adrenoceptor antagonist that has been proven effective and safe for the treatment of essential hypertension. It is comparable to other therapies in blood pressure control while demonstrating an excellent safety profile, favorable hemodynamic activity, and minimal effects on other cardiovascular risk factors. Celiprolol may offer the physician a unique therapeutic alternative.